PKD1P2 and COVID-19: EAS populations harbor both high-frequency ACE2-hg1 (43%) and ACE2-hg2 (53%), indicating differentiation of COVID-19 severities, i.e. the majority will have a lower risk of severe COVID-19, but another half will have a higher risk.